1. News

News Stories

Las Estancias benefits long-underserved area

Albuquerque Journal

Lovelace Medical Group opened a new clinic at Las Estancias, a massive mixed-use commercial development in the South Valley. The Albuquerque Journal covered its importance in this article. 

Heart Hospital of New Mexico at Lovelace Medical Center achieves first implantation of Ovation Alto™ Abdominal Stent Graft System

Press Release

ALBUQUERQUE – April 3, 2017 – Steven Henao, M.D., chief vascular surgeon of New Mexico Heart Institute performed the first implant of the Ovation Alto™ Abdominal Stent Graft system in a patient on Thursday, March 30 at Heart Hospital of New Mexico at Lovelace Medical Center.

The Ovation Alto is manufactured by Endologix Corporation and is designed to treat abdominal aortic aneurysm (AAA).

Dr. Douglas Barrett on Good Day New Mexico for Lovelace Neurosciences Center

KOB

Douglas Barrett, M.D., senior neurologist at Lovelace Neurosciences Center, appeared on Good Day New Mexico March 22 to discuss the new Lovelace Neurosciences Center at 500 Walter St. NE.

You can view the clip here.

 

Lovelace opens neurosciences center

Albuquerque Journal

Lovelace Medical Group opened the new Lovelace Neurosciences Center at 500 Walter St. NE, Suite 401 on March 20. Steven Sinovic at the Albuquerque Journal interviewed John Cruickshank, D.O., CEO of Lovelace Medical Group, regarding the new clinic and what it means for patients to have neurosurgeons, neurologists and other providers in close proximity. 

Las Estancias attracts medical clinics

Albuquerque Journal

In January, 2017, Lovelace Medical Group opened a new clinic in the Las Estancias development of Albuquerque's South Valley. The new location is becoming a hub of economic development in the area, as reported by The Albuquerque Journal's Steve Sinovic. 

Heart Hospital of New Mexico at Lovelace Medical Center implants new WATCHMAN Left Atrial Appendage Closure

Press Release
ALBUQUERQUE – March 8, 2017 – Physicians at Heart Hospital of New Mexico at Lovelace Medical Center recently implanted the WATCHMAN™ Left Atrial Appendage Closure (LAAC) device in a New Mexico patient.
 
The device offers patients with non-valvular atrial fibrillation (AF) an alternative to long-term Warfarin blood-thinning medication.
 
People with atrial fibrillation have a five times greater risk of stroke. Atrial fibrillation can cause blood to pool and form clots in the left atrial appendage (LAA).

Lovelace Westside Hospital named as Top Place to Work in Healthcare 2017

Press Release
FOR IMMEDIATE RELEASE
 
ALBUQUERQUE – March 3, 2017 – Lovelace Westside Hospital was named to Becker’s Hospital Review’s “150 Top Places to Work in Healthcare 2017” list.
 
The hospital was recognized for encouraging professional development among employees and promoting tomorrow’s leaders.

Lovelace Medical Group clinic recognized as Patient Centered Medical Home

Press Release

FOR IMMEDIATE RELEASE

ALBUQUERQUE – February 27, 2017 – Lovelace Medical Group has announced its largest clinic was recently recognized as a Level 1 Patient-Centered Medical Home (PCMH) by the National Committee for Quality Assurance (NCQA). The recognition puts the Lovelace Medical Group on the map as a beacon of high-quality care and service to patients.

Lovelace Medical Center receives national accreditation in radiation oncology

Press Release
ALBUQUERQUE – February 20, 2017 – Lovelace Medical Center has been awarded a three-year term of accreditation in radiation oncology as the result of a recent review by the American College of Radiology (ACR).
 
This accreditation represents the highest level of quality and patient safety in radiation oncology and is awarded only to facilities meeting specific practice guidelines and technical standards.
 
“We are honored to have attained this accreditation in radiation oncology,” said Lovelace Medical Center CEO Tro